MRI Targeted biopsy is performed using cognitive fusion more easily with anatomical guidance based on the radiology report. MRI targets can be identified quickly in real-time along with micro-ultrasound targets, which may have been missed on MRI.
Visualization and targeting of a guided prostate biopsy using the ExactVu micro-ultrasound at a small Gleason 8 lesion. The small hypoechoic lesion is 0.49 cm x 0.61 cm (0.19” x 0.24”) in size. Biopsy was verified by clinical pathology.
Brian Wodlinger, Ph.D.

Historically when a patient had an elevated PSA (prostate specific antigen) test their urologist would take the next step — a prostate biopsy to determine if the increased PSA level was due to cancer or another condition such as infection or benign prostatic hyperplasia. These biopsies were performed using standard ultrasound to identify the prostate.
An interview with Eric Liederman, M.D., MPH, Director of Medical Informatics for The Permanente Medical Group, in Kaiser Permanente’s Northern California Region, on the explosion of telemedicine in the COVID-19 era

I recently had the opportunity to sit down and talk with Eric Liederman, M.D., MPH, Director of Medical Informatics for The Permanente Medical Group, in

Vendor neutral archives enable a single, central location to store large volumes of radiology data, but now need to be able to house data from dozens of other departments with a wide array of data formats. This article originally ran as an introduction to the Vendor Neutral Archives comparison chart.

Most radiologists and clinicians are not trained as information technology (IT) programmers or administrators, so here is a list of 10 questions to ask in order to have meaningful conversations when shopping for a new vendor neutral archive (VNA). 
According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

According to a new research report1 on the contrast media injectors published by MarketsandMarkets, the market was estimated to be $1.3 billion in 2020 and projected to reach $1.9 billion by 2025, at a compound annual growth rate (CAGR) of 7.4 percent over 2020-2025.

January 20, 2021 — A joint team of researchers from Radiation Oncology at Dartmouth's and Dartmouth-Hitchcock's Norris Cotton Cancer Center (NCCC), Dartmouth Engineering, and Dartmouth-Hitchcock's Department of Surgery have developed a method to convert a standard linear accelerator (LINAC), used for delivery of radiation therapy cancer treatment, to a FLASH ultra-high-dose rate radiation therapy beam.

January 20, 2021 — Exact Therapeutics, a clinical stage precision medicine company, announced a collaboration with GE Healthcare to develop an innovative ultrasound probe to be used in forthcoming studies using Acoustic Cluster Therapy (ACT) across multiple disease conditions.

January 20, 2021 — Esaote North America announces that the MyLab X8 Ultrasound System has now been approved in Canada.

January 19, 2021 — Radiation exposure and side effects related to iodine contrast agents are the two main concerns of contrast enhanced computed tomography (CT) examinations.

More complex, longer interventional procedures such as structural heart interventions or this revascularization of a coronary chronic total occlusion (CTO) at Henry Ford Hospital in Detroit, requires angiography imaging systems that have improved image detail and lower radiation dose. However, purchase of new systems was put on hold by many hospitals in 2020 due to the sudden drop in elective procedures and diversion of resources due to the COVID-19. Photo by Dave Fornell.

With the postponement of non-essential elective surgeries and medical procedures in 2020 to conserve medical resources for COVID-19 patients during the start of the pandemic, cardiovascular procedures were severely impacted. The increased costs of caring for COVID patients, personal protective equipment (PPE) and the loss of elective procedure revenue caused a massive financial burden on healthcare providers.
Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now